col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


7 Ergebisse       Seite 1

 [1] 
Springer Science and Business Media LLC: Neuropsychopharmacology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Okt―02 A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial Lindsay W. Victoria, Lauren E. Oberlin, Irena P. Ilieva, Abhishek Jaywant, Dora Kanellopoulos, Catherine Mercaldi, et al. (+8)
2 [GO] 2022―Feb―21 Neuropsychopharmacology (NPP) 2020 report on gender balance among corresponding authors and reviewers: before and during the COVID-19 pandemic Sofiya Hupalo, Keri Martinowich, William A. Carlezon, Chloe J. Jordan
3 [GO] 2021―Mrz―22 The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors Katherine E. Burdick, Caitlin E. Millett
4 [GO] 2021―Feb―17 Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19 Abhishek Jaywant, W. Michael Vanderlind, George S. Alexopoulos, Chaya B. Fridman, Roy H. Perlis, Faith M. Gunning
5 [GO] 2021―Jan―21 Telemedicine for treating mental health and substance use disorders: reflections since the pandemic Alisa B. Busch, Dawn E. Sugarman, Lisa E. Horvitz, Shelly F. Greenfield
6 [GO] 2020―Sep―23 Effects of the COVID-19 pandemic on gender representation among corresponding authors of Neuropsychopharmacology (NPP) manuscripts: submissions during January-June, 2020 Chloe J. Jordan, William A. Carlezon
7 [GO] 2020―Aug―13 Covid-19 and promising solutions to combat symptoms of stress, anxiety and depression Deniz Vatansever, Shouyan Wang, Barbara J. Sahakian
 [1] 

7 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec